TL;DR: The May 2026 Salmonella outbreak linked to MOGO-brand moringa capsules is over, with 34 illnesses in 14 states, 11 hospitalizations and no deaths, and FDA has completed its investigation.

The U.S. Food and Drug Administration has finished investigating the outbreak, which the Centers for Disease Control and Prevention closed on July 17, 2026. In its final update, FDA said MOGO Moringa LLC of St. Louis, Missouri, sourced all of the moringa leaf powder in the capsules from India, and that inspections of the company's ingredient supplier and manufacturer each ended with observations citing deficiencies.

The recalled product is MOGO-brand Pure Moringa Oleifera capsules in white plastic bottles with green labels: lot 15525AA with an expiration of 6/2027 and lot 00926AA with an expiration of 1/2028. They were sold online, including on Amazon, eBay and mogomoringa.com. FDA says the capsules should no longer be available for sale, but because the product has a long shelf life, consumers should check their homes and throw out any bottles they find.

Final tally: 34 illnesses in 14 states

CDC's July 17, 2026 update counts 34 people infected with the outbreak strain across 14 states, with illnesses starting between Aug. 27, 2025, and June 21, 2026. Of 25 patients with information available, 11 were hospitalized, and no deaths were reported.

Interviews supported the link to the capsules. Of 17 people questioned, 14 (82%) reported eating moringa powder capsules and 11 named MOGO. CDC also said one additional person reported eating the capsules while breastfeeding, and that woman's infant was sick with the outbreak strain. Patients ranged in age from 1 to 93, with a median of 63, and 53% were female.

When the investigation opened, the figures were smaller: CDC's May 27, 2026 update listed 18 illnesses in 14 states and seven hospitalizations.

From alert to closure

A Food Safety Magazine report on Aug. 28, 2026, describing FDA's executive incident summary, says the agency's Coordinated Outbreak Response and Evaluation Network learned from CDC on May 13, 2026, of a Salmonella Typhimurium cluster spanning 12 states. MOGO Moringa LLC recalled the two lots on May 25, 2026. Both agencies posted updates on May 27, and the case closed on July 17.

What traceback showed about the supply chain

Traceback records showed that all of MOGO's moringa leaf powder came from India, FDA said. The executive incident summary adds that the Indian supplier bought moringa from two small farms, that the traceback did not show convergence, and that most cases were tied to a single supplier.

Investigators traced capsules eaten by five patients in Florida, Oregon, Tennessee and Washington, plus a TNVitamins Ultrapotent Moringa Powder Capsules product taken by one patient in North Carolina. Where purchase information existed, buyers had ordered through Amazon.

Two inspections, two sets of deficiencies

On May 22, 2026, FDA carried out a dietary supplement inspection that included retain sampling of a supplier. Its Form 483 cited product specifications, contamination limits and adherence to procedures, while every sample collected tested negative.

A June 5, 2026 limited-scope preventive controls inspection by FDA's Division of Foreign Food Inspections and Global Operations/India Office produced a second Form 483. That one cited missing written records and procedures, cleaning and sanitation problems, inadequate hazard controls, personnel practices, and facility design and maintenance.

What product testing showed

Opened containers taken from patients' homes in Washington, Tennessee and Florida tested positive for Salmonella, and whole genome sequencing showed the bacteria were closely related to the patients' samples. Florida's container also held a second strain, identified as Salmonella IV 48:g,z51:-.

Testing predicted no antibiotic resistance in samples from 33 people; one person's sample was predicted to be resistant to tetracycline. CDC said that finding was unlikely to alter treatment choices for most patients, and most people recover without antibiotics.

One safeguard FDA says it added

FDA said it increased screening of moringa powder imported from India for Salmonella. The agency also described this outbreak as separate from earlier 2026 outbreaks tied to moringa powder.

If a recalled bottle is still in your kitchen

FDA's advice is to check the lot code and then discard the capsules rather than eat, sell or distribute them. Containers and surfaces the product touched should be cleaned and sanitized, with extra care to avoid cross-contamination. Anyone who thinks they became ill after taking the capsules should contact a health care provider immediately, FDA said.

Salmonella symptoms usually begin 12 to 72 hours after contaminated food is eaten and last four to seven days, according to FDA. Diarrhea, fever and abdominal cramps are typical, and children younger than five, older adults and people with weakened immune systems are more likely to develop severe infections.

Why moringa keeps producing recalls

Food Safety Magazine described the MOGO outbreak as one of three Salmonella outbreaks linked to moringa supplements in 2026. A separate 2026 outbreak described on FDA's January 2026 outbreak page involved moringa-containing supplements and reached 131 illnesses in 38 states, with 36 hospitalizations and no deaths. In that update, FDA said it continues to work with industry and federal partners to safeguard dietary supplements containing moringa leaf powder.

The problem is not limited to Salmonella. At IDWeek in October 2026, CDC researchers presented the first known U.S. outbreak of carbapenem-resistant Salmonella infections, which Healio reported on Nov. 18, 2026: eight patients in eight states, three of them hospitalized and none dead, with five of six patients interviewed naming the same moringa supplement brand. Susceptibility testing of five clinical isolates showed resistance to all first-line agents and carbapenems. "We tend to focus on things like foods, chicken, eggs and animal exposures ... but it's definitely possible that we have gaps," CDC medical officer Louise Francois Watkins said.

What the public record leaves open

FDA redacted the names of the implicated suppliers and upstream firms in the executive incident summary, Food Safety Magazine reported, so the Indian supplier and the two farms remain publicly unidentified. Traceback also stopped short of convergence on a single upstream source, although most cases were tied to one supplier.

CDC said the reported case count was likely much lower than the true number of illnesses, because many people recover without medical care and are never tested for Salmonella. Its PulseNet system, which stores DNA fingerprints of foodborne bacteria, matched the patients' samples through whole genome sequencing.

Sources referenced